Screening of potential prodrugs on cells derived from Dupuytren’s disease patients (CROSBI ID 144931)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Podaci o odgovornosti
Kraljević Pavelić, Sandra ; Bratulić, Siniša ; Hock, Karlo ; Jurišić, Davor ; Hranjec, Marijana ; Karminski-Zamola, Grace ; Žinić, Biserka ; Bujak, Maro ; Pavelić, Krešimir
engleski
Screening of potential prodrugs on cells derived from Dupuytren’s disease patients
Dupuytren’s Disease (DD) is a fibroproliferative disorder, the cure for which is still limited to surgical excision of the affected fascia, often leading to high recurrence rates. Due to this fact, non-surgical treatments are being investigated, among them those targeting molecular processes of proliferation and differentiation in Dupuytren’ s cell cultures. Drugs with antiproliferative action may be valuable in DD treatment. Through characterization of changes on DD-specific cells, we therefore decided to test the therapeutic potential of new cytostatic drugs for DD treatment and/or for reduction of post-operative recurrence rates. The N-sulphonylpyrimidine derivative, amidino-substituted benzimidazo[1, 2-a]quinoline, and amidino dihydrothienothienyl[2, 3-c]quinolone hydrochloride, known to affect proliferation processes, were tested for their antiproliferative activity on primary fibroblasts/myofibroblasts cell cultures derived from the palmar fascia of patients with DD. Only amidino dihydrothienothienyl[2, 3-c]quinolone hydrochloride acted in a highly specific manner on cells derived from diseased fascia of DD patients and exhibited a low cytotoxic effect. This result might be a consequence of its specific activity on cytoskeleton changes occurring in differentiating cells. A similar short-term differential antiproliferative effect was observed by the N-sulphonylpyrimidine derivative that was however completely lost after 6- and 14-day treatments. The amidino-substituted benzimidazo[1, 2-a]quinoline exerted a strong non-specific, dose-related antiproliferative activity on cell types.
Dupuytren's contracture ; fibroblasts ; myofibroblasts
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
63 (8)
2009.
577-585
objavljeno
0753-3322
1950-6007
10.1016/j.biopha.2008.10.005
Povezanost rada
Kemija, Temeljne medicinske znanosti